Related Experiment Video
Updated: Jul 10, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity
Eun-Joo Kim1, Jeong-Hoon Kho, Moo-Rim Kang
1Department of Bioscience and Biotechnology, Sejong University, 98 Kunja-dong, Kwangjin-gu, Seoul 143-747, Korea. ejk93@hanmail.net
Abstract:
Human SIRT1 is an NAD+-dependent deacetylase protein that plays a role in cell death/survival, senescence, and endocrine signaling. While its substrates, including p53, have been well characterized, no direct regulators are known. We describe here a nuclear protein, active regulator of SIRT1 (AROS), which directly regulates SIRT1 function. AROS enhanced SIRT1-mediated deacetylation of p53 both in vitro and in vivo, and it inhibited p53-mediated transcriptional activity. AROS activity was abrogated by the SIRT1 inhibitors splitomicin and nicotinamide and by SIRT1 small interfering RNA (siRNA). In addition, AROS was unable to cooperate in p53 inactivation in an AROS-binding-defective SIRT1 mutant. Finally, knockdown of endogenous AROS using an antisense expression vector enhanced p21WAF1 expression and increased both the G0/G1 population and apoptosis in response to DNA damage, while AROS overexpression improved cell survival. To our knowledge, AROS is the first direct SIRT1 regulator to be identified that modulates p53-mediated growth regulation.
Insights
Active regulator of SIRT1 (AROS) directly controls SIRT1 deacetylase activity, impacting p53 regulation. This discovery reveals AROS as the first identified SIRT1 regulator, influencing cell survival and growth.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- SIRT1 is a crucial NAD+-dependent deacetylase involved in cell death, survival, senescence, and endocrine signaling.
- While SIRT1 substrates like p53 are known, its direct regulators remain unidentified.
Purpose of the Study:
- To identify and characterize direct regulators of human SIRT1.
- To elucidate the role of AROS in modulating SIRT1 activity and p53 function.
Main Methods:
- In vitro and in vivo assays to assess AROS's effect on SIRT1-mediated p53 deacetylation.
- Utilized SIRT1 inhibitors (splitomicin, nicotinamide) and small interfering RNA (siRNA) to probe AROS-SIRT1 interactions.
- Investigated AROS binding-defective SIRT1 mutants.
- Employed antisense expression vectors for AROS knockdown and assessed effects on p21WAF1 expression, cell cycle, and apoptosis.
Main Results:
- AROS directly enhances SIRT1-mediated deacetylation of p53.
- AROS inhibits p53-mediated transcriptional activity.
- AROS's function is dependent on active SIRT1, as shown by abrogation with inhibitors and siRNA, and failure to cooperate with a binding-defective SIRT1 mutant.
- Knockdown of AROS increases p21WAF1 expression and DNA damage-induced apoptosis, while AROS overexpression promotes cell survival.
Conclusions:
- AROS is identified as the first direct regulator of SIRT1.
- AROS modulates p53 activity, thereby influencing p53-mediated growth regulation.
- AROS plays a significant role in cell survival and response to DNA damage.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Co-activators and Co-repressors
Co-activators and Co-repressors
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
